The Effects of in Ovo Administration of Encapsulated Toll-like Receptor 21 Ligand As an Adjuvant with Marek's Disease Vaccine

Overview

Journal Sci Rep

Specialty Science

Date 2018 Nov 8

PMID 30401976

Citations 8

Authors

Jegarubee Bavananthasivam

Leah Read

Jake Astill

Alexander Yitbarek

Tamiru N Alkie

Mohamed Faizal Abdul-Careem

Sarah K Wootton

Shahriar Behboudi

Shayan Sharif

Affiliations

Soon will be listed here.

Abstract

Marek's Disease Virus (MDV) is the causative agent of a lymphoproliferative disease, Marek's disease (MD) in chickens. MD is only controlled by mass vaccination; however, immunity induced by MD vaccines is unable to prevent MDV replication and transmission. The herpesvirus of turkey (HVT) vaccine is one of the most widely used MD vaccines in poultry industry. Vaccines can be adjuvanted with Toll-like receptor ligands (TLR-Ls) to enhance their efficacy. In this study, we examined whether combining TLR-Ls with HVT can boost host immunity against MD and improve its efficacy. Results demonstrated that HVT alone or HVT combined with encapsulated CpG-ODN partially protected chickens from tumor incidence and reduced virus replication compared to the control group. However, encapsulated CpG-ODN only moderately, but not significantly, improved HVT efficacy and reduced tumor incidence from 53% to 33%. Further investigation of cytokine gene profiles in spleen and bursa of Fabricius revealed an inverse association between interleukin (IL)-10 and IL-18 expression and protection conferred by different treatments. In addition, the results of this study raise the possibility that interferon (IFN)-β and IFN-γ induced by the treatments may exert anti-viral responses against MDV replication in the bursa of Fabricius at early stage of MDV infection in chickens.

Citing Articles

In Ovo Vaccination with Recombinant Herpes Virus of the Turkey-Laryngotracheitis Vaccine Adjuvanted with CpG-Oligonucleotide Provides Protection against a Viral Challenge in Broiler Chickens.

Gaghan C, Browning M, Fares A, Abdul-Careem M, Gimeno I, Kulkarni R Viruses. 2023; 15(10).

PMID: 37896880 PMC: 10612038. DOI: 10.3390/v15102103.

Application of structural equation modelling to inform best management strategies for Marek's disease in Amhara region, Ethiopia.

Birhan M, Berhane N, Ibrahim S, Dejene H, Dessalegn B, Woldemichael W Sci Rep. 2023; 13(1):10592.

PMID: 37391473 PMC: 10313769. DOI: 10.1038/s41598-023-37636-6.

Effect of CpG-Oligonucleotide in Enhancing Recombinant Herpes Virus of Turkey-Laryngotracheitis Vaccine-Induced Immune Responses in One-Day-Old Broiler Chickens.

Gaghan C, Browning M, Cortes A, Gimeno I, Kulkarni R Vaccines (Basel). 2023; 11(2).

PMID: 36851171 PMC: 9965839. DOI: 10.3390/vaccines11020294.

Characterization of Dosage Levels for In Ovo Administration of Innate Immune Stimulants for Prevention of Yolk Sac Infection in Chicks.

Sarfraz M, Nguyen T, Wheler C, Koster W, Gerdts V, Dar A Vet Sci. 2022; 9(5).

PMID: 35622731 PMC: 9142911. DOI: 10.3390/vetsci9050203.

The Regulatory Microenvironment in Feathers of Chickens Infected with Very Virulent Marek's Disease Virus.

Bavananthasivam J, Alqazlan N, Alizadeh M, Matsuyama-Kato A, Astill J, Kulkarni R Viruses. 2022; 14(1).

PMID: 35062316 PMC: 8781056. DOI: 10.3390/v14010112.

References

Nair V . Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host. Vet J. 2005; 170(2):175-83. DOI: 10.1016/j.tvjl.2004.05.009. View

Abdul-Careem M, Haq K, Shanmuganathan S, Read L, Schat K, Heidari M . Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek's disease virus. Virology. 2009; 393(2):250-7. DOI: 10.1016/j.virol.2009.08.001. View

Abdul-Careem M, Hunter B, Parvizi P, Haghighi H, Thanthrige-Don N, Sharif S . Cytokine gene expression patterns associated with immunization against Marek's disease in chickens. Vaccine. 2006; 25(3):424-32. DOI: 10.1016/j.vaccine.2006.08.006. View

Alkie T, Taha-Abdelaziz K, Barjesteh N, Bavananthasivam J, Hodgins D, Sharif S . Characterization of Innate Responses Induced by PLGA Encapsulated- and Soluble TLR Ligands In Vitro and In Vivo in Chickens. PLoS One. 2017; 12(1):e0169154. PMC: 5207720. DOI: 10.1371/journal.pone.0169154. View

Parvizi P, Read L, Abdul-Careem M, Sarson A, Lusty C, Lambourne M . Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically resistant and susceptible chickens infected with Marek's disease virus. Vet Immunol Immunopathol. 2009; 132(2-4):209-17. DOI: 10.1016/j.vetimm.2009.06.009. View

Lowenthal J, Connick T, McWaters P, York J . Development of T cell immune responsiveness in the chicken. Immunol Cell Biol. 1994; 72(2):115-22. DOI: 10.1038/icb.1994.18. View

Hsu P, Santner-Nanan B, Hu M, Skarratt K, Lee C, Stormon M . IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1. J Immunol. 2015; 195(8):3665-74. DOI: 10.4049/jimmunol.1402898. View

Quere P, Dambrine G . Development of anti-tumoral cell-mediated cytotoxicity during the course of Marek's disease in chickens. Ann Rech Vet. 1988; 19(3):193-201. View

Heller E, Schat K . Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol. 1987; 16(1):51-60. DOI: 10.1080/03079458708436352. View

10.

Negash T, al-Garib S, Gruys E . Comparison of in ovo and post-hatch vaccination with particular reference to infectious bursal disease. A review. Vet Q. 2004; 26(2):76-87. DOI: 10.1080/01652176.2004.9695170. View

11.

Witter R, Calnek B, Buscaglia C, Gimeno I, Schat K . Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol. 2005; 34(2):75-90. DOI: 10.1080/03079450500059255. View

12.

Rothwell L, Young J, Zoorob R, Whittaker C, Hesketh P, Archer A . Cloning and characterization of chicken IL-10 and its role in the immune response to Eimeria maxima. J Immunol. 2004; 173(4):2675-82. DOI: 10.4049/jimmunol.173.4.2675. View

13.

Islam A, Wong C, Walkden-Brown S, Colditz I, Arzey K, Groves P . Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge. Avian Pathol. 2002; 31(5):449-61. DOI: 10.1080/0307945021000005824. View

14.

Djeraba A, Bernardet N, Dambrine G, Quere P . Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. Virology. 2000; 277(1):58-65. DOI: 10.1006/viro.2000.0576. View

15.

Parvizi P, Mallick A, Haq K, Schlegel B, Sharif S . A Toll-like receptor 3 agonist (polyI:C) elicits innate host responses in the spleen and lungs of chickens. Can J Vet Res. 2013; 76(3):230-4. PMC: 3384288. View

16.

Parvizi P, Abdul-Careem M, Mallick A, Haq K, Haghighi H, Orouji S . The effects of administration of ligands for Toll-like receptor 4 and 21 against Marek's disease in chickens. Vaccine. 2014; 32(17):1932-8. DOI: 10.1016/j.vaccine.2014.01.082. View

17.

Haq K, Wootton S, Barjesteh N, Golovan S, Bendall A, Sharif S . Effects of interferon-γ knockdown on vaccine-induced immunity against Marek's disease in chickens. Can J Vet Res. 2015; 79(1):1-7. PMC: 4283228. View

18.

Kaiser P, Underwood G, Davison F . Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol. 2002; 77(1):762-8. PMC: 140586. DOI: 10.1128/jvi.77.1.762-768.2003. View

19.

Abdul-Careem M, Hunter B, Lee L, Fairbrother J, Haghighi H, Read L . Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus. Virology. 2008; 379(2):256-65. DOI: 10.1016/j.virol.2008.06.027. View

20.

Mallick A, Kulkarni R, St Paul M, Parvizi P, Nagy E, Behboudi S . Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens. Viral Immunol. 2012; 25(3):226-31. DOI: 10.1089/vim.2011.0085. View